Jean Suehl, APRN
Gerontology · Norfolk, NENPI 1861706756
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 170 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $929 and has fallen 65.4% since, to $321 in 2025. Among gerontology clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 170 payments — averaging $15.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$330
- Organogenesis Inc.$243
- AbbVie$171
- Lilly USA, LLC$170
- Novo Nordisk$157
- Amarin Pharma, Inc.$153
- plus $1K from 32 others
What the payments were for
- Food & beverage$2,692100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 28 | $330 |
| Organogenesis Inc. | 9 | $243 |
| AbbVie | 8 | $171 |
| Lilly USA, LLC | 12 | $170 |
| Novo Nordisk | 11 | $157 |
| Amarin Pharma, Inc. | 12 | $153 |
| Boehringer Ingelheim | 8 | $139 |
| Integra Lifesciences Corporation | 3 | $130 |
| Pfizer | 11 | $124 |
| AstraZeneca | 8 | $102 |
| Merck | 6 | $100 |
| Teva Pharmaceuticals USA, Inc. | 5 | $93 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Astellas Pharma US Inc | 5 | $74 |
| Sanofi-aventis U.S. LLC | 3 | $55 |
| Zealand Pharma US, Inc. | 3 | $53 |
| Daiichi Sankyo Inc. | 3 | $52 |
| Novartis | 3 | $44 |
| E.r. Squibb & Sons, L.L.C. | 3 | $42 |
| Convatec Inc. | 2 | $40 |
| Lifenet Health | 2 | $32 |
| Ultragenyx Pharmaceutical Inc. | 2 | $31 |
| Johnson & Johnson | 2 | $28 |
| Bayer | 2 | $27 |
| Grifols USA, LLC | 2 | $26 |
| Acera Surgical, Inc. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Biogen | 1 | $17 |
| KCI USA, Inc. | 1 | $16 |
| Acadia Pharmaceuticals Inc | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| GSK | 1 | $14 |
| Smith+Nephew | 1 | $14 |
| Dexcom, Inc. | 1 | $12 |
How this compares
$2,692 in reported general payments places this provider in the 95th percentile of 21 gerontology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 75 | $48,894 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $18,225 |
| JardianceEmpagliflozin | 50 | $17,948 |
| TrulicityDulaglutide | 16 | $14,609 |
| MounjaroTirzepatide | 14 | $13,519 |
| MyrbetriqMirabegron | 16 | $11,072 |
| FarxigaDapagliflozin Propanediol | 15 | $9,613 |
| Memantine Hcl | 80 | $7,541 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 20 | $6,605 |
| SymbicortBudesonide/Formoterol Fumarate | 15 | $3,425 |
| Admelog SolostarInsulin Lispro | 13 | $2,647 |
| Atorvastatin Calcium | 246 | $2,402 |
| Potassium Chloride | 71 | $2,242 |
| Levothyroxine Sodium | 222 | $2,230 |
| Sertraline Hcl | 191 | $1,716 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $124 | $48,89475 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $170 | $28,12830 claims |
| GSKTrelegy Ellipta | $14 | $18,22527 claims |
| Boehringer IngelheimJardiance | $139 | $17,94850 claims |
| AstraZenecaFarxiga, Symbicort | $102 | $13,03830 claims |
| Astellas Pharma US IncMyrbetriq | $74 | $11,07216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 21 gerontology providers in Nebraska.
Other gerontology in Norfolk
- April SmithLincoln$4K
- Jenny DankertOmaha$3K
- Tara PetersonOmaha$2K
- Deborah SheldonKearney$2K
- Amy StumpKearney$990
- Irish MillsOmaha$670
- Michelle SchielGrand Island$663
- Alexis CushmanOmaha$555
- Marie BissellLincoln$510
- Melissa BowenLincoln$338
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.